Calprofen Ibuprofen Suspension Sachets, Sugar & Colour Free, Pain & Fever Relief for 3+ Months, Strawberry Flavour, 5 ml, 12-Count

Product Information

Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens- Johnson syndrome, and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs (see section 4.8). Patients appear to be at highest risk for these reactions early in the course of therapy: the onset of the reaction occurring in the majority of cases within the first month of treatment. Acute generalised exanthematous pustulosis (AGEP) has been reported in relation to ibuprofen-containing products. Ibuprofen 100mg/5ml Oral Suspension should be discontinued at the first appearance of signs and symptoms of severe skin reactions, such as skin rash, mucosal lesion, or any other sign of hypersensitivity.

Never use ibuprofen gel, mousse or spray on your eyes, mouth, lips, nose or genital area. It may make them sore. Do not put it on sore or broken skin.Speak with a doctor before taking ibuprofen if you have ever had a bad reaction to any other anti-inflammatory painkiller. If you have asthma, symptoms such as wheeze or breathlessness can be made worse by anti-inflammatories such as ibuprofen. If this happens to you, you should stop taking ibuprofen and see your doctor as soon as possible. Inhibition of uterine contractions, which may result in delayed or prolonged labour. Consequently, ibuprofen is contraindicated during the third trimester of pregnancy. Lactation

Gently massage the ibuprofen into the painful area 3 or 4 times a day. Leave at least 4 hours between applications. If you're taking ibuprofen for a short-lived pain like toothache or period pain, you may only need to take it for a day or two.Hearst UK is the trading name of the National Magazine Company Ltd, 30 Panton Street, Leicester Square, London, SW1Y 4AJ. Registered in England. All Rights Reserved. When GI bleeding or ulceration occurs in patients receiving Ibuprofen, the treatment should be withdrawn. Medicines that you can buy from the supermarket or pharmacy may contain Ibuprofen (this information is given on the label). Do not give such medicines to your child if you have given them Ibuprofen, as you risk giving them too much. If you take ibuprofen 3 times a day, leave at least 6 hours between doses. If you take it 4 times a day, leave at least 4 hours between doses. Ibuprofen should not be used in patients who have previously shown hypersensitivity reactions (e.g. asthma, urticaria, angioedema or rhinitis) after taking ibuprofen, aspirin or other NSAIDs.

Brufen should be given with care to patients with a history of heart failure or hypertension since oedema has been reported in association with ibuprofen administration. As with other NSAIDs, long-term administration of ibuprofen has resulted in renal papillary necrosis and other renal pathologic changes. Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. In these patients, administration of an NSAID may cause a dose dependant reduction in prostaglandin formation and, secondarily, in renal blood flow, which may cause renal failure.

If they take too much

Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens- Johnson syndrome, and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs (see section 4.8). Patients appear to be at highest risk of these reactions early in the course of therapy, the onset of the reaction occurring within the first month of treatment in the majority of cases. Acute generalised exanthematous pustulosis (AGEP) has been reported in relation to ibuprofen-containing products. Ibuprofen should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity. Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Brufen should not be given to patients with conditions involving an increased tendency to bleeding. Anticoagulants: NSAIDs may enhance the effects of anticoagulants, such as warfarin (see section 4.4).